The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative https://campbelld197blv6.azzablog.com/profile